Bodisen Biotech, Inc. (ˇ°Bodisenˇ± or the ˇ°Companyˇ±)
The Company announces that an application has been made for 165,333 common stock of $0.0001 each to be admitted to trading on AIM. The common stock will rank pari passu with the existing issued stock of the Company and dealings are expected to commence on 29 June 2007.
This common stock has been issued pursuant to the exercise of warrants. The Company received proceeds of $1,220,160 from the exercise. Warrants were issued to Amaranth Partners L.L.C. pursuant to the $5 million short term promissory note facility that was made available to Bodisen on 8 December 2005 and as previously announced on 20 March 2006, was repaid in full from a placing undertaken at that time.
Following this, the total number of voting rights in issue will be 18,310,250.
Charles Stanley Securities (Nominated Adviser)
Rick Thompson / Philip Davies / Carl Holmes - 0207 149 6000